{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:02:51Z","timestamp":1775570571945,"version":"3.50.1"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A sinus pause is is defined as a delay in sinus node depolarization exceeding 3\u2005s following atrial depolarization. In patients with pauses greater than 5\u2005s accompanied by hemodynamic compromise, the primary treatment is permanent pacemaker (PPM) implantation. However, in the presence of an active infection, alternative strategies such as temporary transvenous pacing or pharmacologic agents may be more appropriate. This report highlights the use of theophylline as a non-invasive therapeutic option in two patients with asymptomatic sinus pauses who had contraindications to PPM placement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Cases<\/jats:title>\n                    <jats:p>\n                      Patient A was a 74-year-old woman with a history of pulmonary arterial hypertension treated with subcutaneous treprostinil and a recent episode of catheter-associated\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      bacteremia, for which she was receiving chronic suppressive doxycycline. She was admitted for acute decompensated heart failure. Patient B was a 24-year-old man with a history of cerebral palsy and chronic respiratory failure who was admitted for bacterial pneumonia. While in the intensive care unit, both patients experienced recurrent, asymptomatic sinus pauses lasting up to 8.6\u2005s.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Given their active infections, both patients were deemed poor candidates for device placement and were therefore initiated on theophylline. Within 24\u2005h of initiation, the sinus pauses resolved in both patients. Theophylline doses were adjusted to maintain a therapeutic concentration between 10 and 20\u2005\u00b5g\/mL. Later during hospitalization, Patient A developed atrial fibrillation with rapid ventricular response, prompting discontinuation of theophylline. Patient B was discharged on theophylline 50\u2005mg twice daily, along with a 30-day event monitor and cardiology follow-up. Theophylline exerts its positive chronotropic effects primarily through non-selective phosphodiesterase inhibition and adenosine-1 receptor antagonism. These mechanisms enhance automaticity and reduce atrioventricular node refractoriness, augmenting sinus node automaticity and reducing the frequency and duration of sinus pauses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While these cases highlight the potential role of theophylline as a temporizing pacing strategy, additional research is needed to determine whether and how theophylline can be safely incorporated into treatment protocols for patients who are not suitable for device-based pacing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1731993","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T06:37:48Z","timestamp":1771223868000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-world use of theophylline in critically ill patients with sinus pauses: a case series"],"prefix":"10.3389","volume":"13","author":[{"given":"Muhammad Ali","family":"Elahi","sequence":"first","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Jalal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Frick","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan D.","family":"Kraft","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1164\/rccm.200701-031OC","article-title":"Incidence and prognosis of sustained arrhythmias in critically ill patients","volume":"178","author":"Annane","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1016\/j.hrthm.2018.10.037","article-title":"2018 ACC\/AHA\/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay","volume":"16","author":"Kusumoto","year":"2019","journal-title":"Heart Rhythm"},{"key":"B3","first-page":"179","article-title":"Sinus node dysfunction","volume":"104","author":"Hawks","year":"2021","journal-title":"Am Fam Physician"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e15536","DOI":"10.1097\/MD.0000000000015536","article-title":"Chinese Patent medicine to treat a 32-year-old man with sinus bradycardia and cardiac sinus arrests: a case report","volume":"98","author":"Yan","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.hrthm.2023.02.003","article-title":"Concomitant leadless pacing in pacemaker-dependent patients undergoing transvenous lead extraction for active infection: mid-term follow-up","volume":"20","author":"Beccarino","year":"2023","journal-title":"Heart Rhythm"},{"key":"B6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/jocs.14058","article-title":"Epicardial pacemaker as a bridge for pacemaker-dependent patients undergoing explantation of infected cardiac implantable electronic devices","volume":"34","author":"Al-Maisary","year":"2019","journal-title":"J Card Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jacep.2020.06.023","article-title":"Cardiac implantable electronic devices following heart transplantation","volume":"6","author":"DeFilippis","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/biomedicines10112963","article-title":"Adenosine and adenosine receptors: advances in atrial fibrillation","volume":"10","author":"Maille","year":"2022","journal-title":"Biomedicines"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.21037\/jtd-23-1781","article-title":"A narrative review of theophylline: is there still a place for an old friend?","volume":"16","author":"Scurek","year":"2024","journal-title":"J Thorac Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0167-4943(96)86940-8","article-title":"Clinical effects of oral theophylline in elderly patients with sick sinus syndrome","volume":"22","author":"Verza","year":"1996","journal-title":"Arch Gerontol Geriatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1161\/01.CIR.96.1.260","article-title":"Effects of permanent pacemaker and oral theophylline in sick sinus syndrome: the THEOPACE study: a randomized controlled trial","volume":"96","author":"Alboni","year":"1997","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/europace\/euab300","article-title":"Theophylline in patients with syncope without prodrome, normal heart, and normal electrocardiogram: a propensity-score matched study verified by implantable cardiac monitor","volume":"24","author":"Brignole","year":"2022","journal-title":"EP Europace"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1412376","DOI":"10.3389\/fcvm.2024.1412376","article-title":"Oral theophylline corrects sinus node dysfunction in acute on chronic lithium toxicity: case report and systematic review of lithium-induced sinus node dysfunction","volume":"11","author":"Henson","year":"2024","journal-title":"Front Cardiovasc Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1731993\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:31:36Z","timestamp":1771929096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1731993\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":13,"alternative-id":["10.3389\/fcvm.2026.1731993"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1731993","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"article-number":"1731993"}}